Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan Africa

Elizabeth Shayo, Marie Claire Van Hout, Josephine Birungi, Anupam Garrib, Sokoine Kivuyo, Sayoki Mfinanga, Moffat J. Nyrienda, Ivan Namakoola, Joseph Okebe, Kaushik Ramaiya, Max Oscar Bachmann, Walter Cullen, Jeffrey V. Lazarus, Geoff Gill, Tinevimbo Shiri, Dominic Bukenya, Hazel Snell, Mastula Nanfuka, Luis E. Cuevas, Meshack ShimwelaGerald Mutungi, Joshua Musinguzi, Janneth Mghamba, Kenneth Mugisha, Shabbar Jaffar, Peter G. Smith, Nelson Kaulukusi Sewankambo

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
8 Downloads (Pure)


Conducting intervention studies in Africa, where medicines supply for chronic conditions is inequitable and patchy, raises major ethical issues.

Here we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension.
Original languageEnglish
Article numbere002193
JournalBMJ Global Health
Issue number7
Early online date6 Jul 2020
Publication statusPublished - 6 Jul 2020

Cite this